Sign in

CIK 0001434647

  • Non-accelerated filer
  • Smaller reporting company

ZEVRA THERAPEUTICS, INC.

Sign in to watch
Ticker
ZVRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
205894398
Phone
+1 888-958-1253
Business address
101 FEDERAL STREET, BOSTON, MA, 02110
Former names
KEMPHARM, INC, KEMPHARM INC
  1. 4 Planned sale Chief Medical Officer sold 4,533 shares at $8.83 ($40,036)
  2. 4 Planned sale CCO sold 3,375 shares at $8.83 ($29,800)
  3. 4 Planned sale President and CEO sold 91,000 shares at $9.38 ($853,425)
  4. 4 Shares withheld for taxes Former CFO & Treasurer gave up 48,513 shares (to pay taxes)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Planned sale President and CEO sold 19,500 shares at $10.82 ($210,908)
  8. 4 Open-market buy Director bought 3,175 shares at $7.79 ($24,718)
  9. 4 Open-market buy Director bought 20,000 shares at $7.89 ($157,800)
  10. 4 Open-market buy Director bought 5,000 shares at $9.17 ($45,825)
  11. 4 Planned sale Chief Legal & Compliance sold 24,000 shares at $9.21 ($221,004)
  12. 4 Exercise or conversion Chief Legal & Compliance acquired 66,666 shares (option exercise)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy Director bought 300 shares at $7.84 ($2,352)

Page 2 of 16 · 314 filings